STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G

AM6 Schedule 13G filing by UBS

UBS reported beneficial ownership of 17.1M shares, representing 5.5% of AMICUS THERAPEUTICS INC in this filing.

FiledMay 7, 2026
Ownership dateMar 31, 2026
Reported shares17.1M
Reported ownership5.5%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 0
Shared voting power 17.1M
Sole dispositive power 0
Shared dispositive power 14.2M
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
UBS
CIK
CIK0001610520
Accession
0001610520-26-000058
Form
Schedule 13G
Open SEC filing View AM6 ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →